Zentalis Pharmaceuticals Market Sentiment

Zentalis Pharmaceuticals Inc

ZNTLNASDAQ

Trade with Public

$3.68

-0.025-0.67%

At close: Aug 18, 5:00 PM EST

$3.63

-0.05-1.36%

After Hours: 5:43 PM EST

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Zentalis Pharmaceuticals Market Sentiment

Market sentiment signals for Zentalis Pharmaceuticals (ZNTL): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 9.7% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

11 analysts

Options Flow (P/C)

0.00

More calls — Bullish

1,979 calls · 0 puts

Avg Consensus PT

+135.8%

Highest Price Target

$20

+451.0%

Oppenheimer

Lowest Price Target

-39.4%

UBS

Short Interest

9.7%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Jul 23, 2026	Rodman & Renshaw	——	+203.0%	$11	Initiate	Buy
Jul 17, 2026	Mizuho	Graig Suvannavejh—	+120.4%	$8	Initiate	Outperform
Apr 10, 2026	Guggenheim	Michael Schmidt—	+175.5%	$6 → $10	Maintained	Buy
Mar 27, 2026	Guggenheim	Michael Schmidt—	+65.3%	$6 → $6	Maintained	Buy
Nov 12, 2025	Morgan Stanley	Matthew Harrison—	+10.2%	$8 → $4	Maintained	Equal-Weight
Aug 7, 2025	Wells Fargo	Derek Archila—	+37.7%	$6 → $5	Maintained	Equal-Weight
May 15, 2025	Wedbush	Robert Driscoll—	+10.2%	$4 → $4	Maintained	Neutral
May 15, 2025	HC Wainwright & Co.	Andres Maldonado—	+175.5%	$10 → $10	Maintained	Buy
Mar 28, 2025	Wedbush	Robert Driscoll—	+10.2%	$4 → $4	Maintained	Neutral
Mar 27, 2025	HC Wainwright & Co.	Andrew Fein—	+175.5%	$10 → $10	Maintained	Buy
Mar 17, 2025	HC Wainwright & Co.	Andrew Fein—	+175.5%	$10 → $10	Maintained	Buy
Jan 30, 2025	Wells Fargo	Derek Archila—	+65.3%	$8 → $6	Maintained	Equal-Weight
Jan 29, 2025	HC Wainwright & Co.	Andrew Fein—	+175.5%	$20 → $10	Maintained	Buy
Jan 28, 2025	UBS	Eliana Merle—	-39.4%	$5 → $2	Maintained	Neutral
Nov 15, 2024	Guggenheim	Michael Schmidt—	+120.4%	$12 → $8	Maintained	Buy
Nov 15, 2024	HC Wainwright & Co.	Andrew Fein—	+451.0%	$20 → $20	Maintained	Buy
Sep 16, 2024	Oppenheimer	Matthew Biegler—	+451.0%	$20 → $20	Maintained	Outperform
Aug 12, 2024	Wedbush	Robert Driscoll—	+10.2%	$4	Upgrade	Underperform→Neutral
Aug 12, 2024	HC Wainwright & Co.	Andrew Fein—	+451.0%	$20 → $20	Maintained	Buy
Jun 20, 2024	UBS	Eliana Merle—	+37.7%	$28 → $5	Downgrade	Buy→Neutral
Jun 18, 2024	Wells Fargo	Derek Archila—	+147.9%	$29 → $9	Downgrade	Overweight→Equal-Weight
Jun 18, 2024	Stifel	Bradley Canino—	+175.5%	$32 → $10	Maintained	Buy
Jun 18, 2024	HC Wainwright & Co.	Andrew Fein—	+451.0%	$40 → $20	Maintained	Buy
Jun 18, 2024	Oppenheimer	Matthew Biegler—	+588.7%	$50 → $25	Maintained	Outperform
Jun 18, 2024	Morgan Stanley	Matthew Harrison—	+120.4%	$38 → $8	Downgrade	Overweight→Equal-Weight